Skip to main content

We narrowed to 29,147 results for: tat

Showing: 581 - 600 of 29147 results
  1. pTwist-SARS-CoV-2 Spike-deltaC18 VOC-501Y.V2 (B.1.351) - All Mutations

    Plasmid
    #212381
    Purpose
    Encodes SARS-CoV-2 spike L18F,D80A,D215G,L242H,A243I,Q414N,E484K,N501Y,D614G,A701V for pseudovirus production
    Depositor
    Insert
    SARS-CoV-2 Spike L18F,D80A,D215G,L242H,A243I,Q414N,E484K,N501Y,D614G,A701V (S Severe acute respiratory syndrome coronavirus 2)
    Expression
    Mammalian
    Mutation
    L18F,D80A,D215G,L242H,A243I,Q414N,E484K,N501Y,D61…
    Promoter
    CAG
    Available Since
    Sept. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. pTwist-SARS-CoV-2 Spike-deltaC18 D614G (GGT) Q677H (CAT) D936Y (TAT)

    Plasmid
    #212379
    Purpose
    Encodes SARS-CoV-2 spike D614G, Q677H, D936Y for pseudovirus production
    Depositor
    Insert
    SARS-CoV-2 Spike D614G, Q677H, D936Y (S Severe acute respiratory syndrome coronavirus 2)
    Expression
    Mammalian
    Mutation
    D614G, Q677H, D936Y
    Promoter
    CAG
    Available Since
    Sept. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  3. pTwist-SARS-CoV-2 Spike-deltaC18 SAK006840 VOC-501Y.V2 (B.1.351v3) - No RBD Mutations

    Plasmid
    #212380
    Purpose
    Encodes SARS-CoV-2 spike D80A, deltaL242-L244, R246I, D614G, A701V for pseudovirus production
    Depositor
    Insert
    SARS-CoV-2 Spike D80A, G215D, deltaL242-L244, R246I, D614G, A701V (S Severe acute respiratory syndrome coronavirus 2)
    Expression
    Mammalian
    Mutation
    D80A, G215D, deltaL242-L244, R246I, D614G, A701V
    Promoter
    CAG
    Available Since
    Sept. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  4. LentiX-(loxPcon-TET-DIAL-YB-TATA)-mCherry-HRasG12V-bGH-EFS-rtTA-TagBFP-WPRE

    Plasmid
    #246367
    Purpose
    loxPcon TET-DIAL Reporter Lentivirus with YB_TATA expressing mCherry-HRasG12V in the presence of DOX and rtTA and editable by Cre recombinase. Contains rtTA-TagBFP expressed divergenty.
    Depositor
    Insert
    mCherry-GS-HRasG12V (HRAS Human)
    Use
    Lentiviral and Synthetic Biology
    Mutation
    G12V
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only
  5. pCL051 AAVS1-9xTetO-nTATAchr21-IGKleader-Cas9site-hIgG1_FC-Myc-PDGFRb-T2A-Citrine-PolyA

    Plasmid
    #188745
    Purpose
    Donor vector for integrating nonTATAchr21 promoter-driven dual surface marker/mCitrine fluorescent reporter at AAVS1 locus
    Insert
    Surface marker and mCitrine reporter
    Use
    Synthetic Biology
    Expression
    Mammalian
    Promoter
    nonTATAchr21
    Available Since
    May 7, 2024
    Availability
    Academic Institutions and Nonprofits only
  6. pCL053 AAVS1-9xTetO-nTATAchrX-IGKleader-Cas9site-hIgG1_FC-Myc-PDGFRb-T2A-Citrine-PolyA

    Plasmid
    #188746
    Purpose
    Donor vector for integrating nonTATAchrX promoter-driven dual surface marker/mCitrine fluorescent reporter at AAVS1 locus
    Insert
    Surface marker and mCitrine reporter
    Use
    Synthetic Biology
    Expression
    Mammalian
    Promoter
    nonTATAchrX
    Available Since
    May 7, 2024
    Availability
    Academic Institutions and Nonprofits only
  7. pSLQ8629 pHR-HREYBTATA-RR12EE345L-C term (406) dLbCpf1-2XNLS-miniVPR-mCherry-EFS-Puro-WPRE

    Plasmid
    #140227
    Purpose
    Hypoxia-inducible expression of leucine zipper with C terminal dCpf1 (Cas12a) 406-split half fused to miniVPR. Constitutive EFS-driven puromycin resistance.
    Depositor
    Insert
    zipper with dLbCpf1 (Cas12a) C terminal half (406) fused to miniVPR
    Use
    Lentiviral
    Expression
    Mammalian
    Promoter
    HRE (Hypoxia inducible)
    Available Since
    April 21, 2020
    Availability
    Academic Institutions and Nonprofits only
  8. WNV strain-NY99 NS2B-NS3 protease fusion with non cleavable linker with mutation K to A to reduce autoproteolysis

    Plasmid
    #228660
    Purpose
    Bacterial expression of the fusion of the NS2B-NS3 protease from West Nile virus with an H163A - catalytically inactive mutation for xxxxx
    Insert
    West Nile portion of NS2B protease fused to NS3
    Tags
    His-Twin Strep-Tev
    Expression
    Bacterial
    Mutation
    H163A - catalytically inactive/West Nile Virus NS…
    Available Since
    Feb. 18, 2025
    Availability
    Industry, Academic Institutions, and Nonprofits
  9. pTwist-SARS-CoV-2 Spike-deltaC18 Q493R (CGA) Q498R (CGA) N501Y (TAT) Y505H (CAT)

    Plasmid
    #212498
    Purpose
    Encodes SARS-CoV-2 spike Q493R, Q498R, N501Y, Y505H for pseudovirus production
    Depositor
    Insert
    SARS-CoV-2 Spike Q493R, Q498R, N501Y, Y505H (S Severe acute respiratory syndrome coronavirus 2)
    Expression
    Mammalian
    Mutation
    Q493R, Q498R, N501Y, Y505H
    Promoter
    CAG
    Available Since
    Sept. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  10. pTwist-SARS-CoV-2 Spike-deltaC18 Q493R (CGA) G496S (TCA) Q498R (CGA) N501Y (TAT) Y505H (CAT)

    Plasmid
    #212477
    Purpose
    Encodes SARS-CoV-2 spike Q493R, G496S, Q498R, N501Y, Y505H for pseudovirus production
    Depositor
    Insert
    SARS-CoV-2 Spike Q493R, G496S, Q498R, N501Y, Y505H (S Severe acute respiratory syndrome coronavirus 2)
    Expression
    Mammalian
    Mutation
    Q493R, G496S, Q498R, N501Y, Y505H
    Promoter
    CAG
    Available Since
    Sept. 13, 2024
    Availability
    Academic Institutions and Nonprofits only
  11. pTriEx-HTNC

    Plasmid
    #13763
    Purpose
    For expression and purification of a His-TAT-NLS-Cre fusion; HIV-TAT promotes cellular uptake of recombinant Cre into mammalian cells.
    Depositor
    Insert
    His-TAT-NLS-Cre
    Use
    Baculovirus
    Tags
    His Tag, NLS, and TAT
    Expression
    Bacterial
    Promoter
    p10 promoter
    Available Since
    April 12, 2007
    Availability
    Academic Institutions and Nonprofits only
  12. pACAGW-ChR2-Venus-AAV (AAV1)

    Viral Prep
    #20071-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAGG
    Tags
    Venus
    Available Since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only
  13. pACAGW-ChR2-Venus-AAV (AAV9)

    Viral Prep
    #20071-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAGG
    Tags
    Venus
    Available Since
    March 15, 2018
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-CAG-emiRFP670 (AAV1)

    Viral Prep
    #197200-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-emiRFP670 (#197200). In addition to the viral particles, you will also receive purified pAAV-CAG-emiRFP670 plasmid DNA. CAG-driven expression of emiRFP670. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Feb. 7, 2025
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV-EF1α-F-FLEX-mNaChBac-T2A-tdTomato (AAV8)

    Viral Prep
    #60658-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1α-F-FLEX-mNaChBac-T2A-tdTomato (#60658). In addition to the viral particles, you will also receive purified pAAV-EF1α-F-FLEX-mNaChBac-T2A-tdTomato plasmid DNA. CAG-driven, Flp-dependent expression of the voltage-gated Na+ channel mNaChBac-T2A-tdTomato. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1α
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV-CAG-LiLac (AAV8)

    Viral Prep
    #184570-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-LiLac (#184570). In addition to the viral particles, you will also receive purified pAAV-CAG-LiLac plasmid DNA. CAG-driven expression of lactate sensor LiLac. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (AAV9)

    Viral Prep
    #35499-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (#35499). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP plasmid DNA. CaMKIIa-driven, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EYFP
    Available Since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE (AAV2)

    Viral Prep
    #203847-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE (#203847). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-rc[Chronos-eGFP]-WPRE plasmid DNA. Ef1a-driven, Flp-dependent expression of Chronos-EGFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Jan. 15, 2026
    Availability
    Academic Institutions and Nonprofits only
  19. pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (AAV9)

    Viral Prep
    #35497-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (#35497). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP plasmid DNA. EFIa-driven, Cre-dependent, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EYFP (Cre-dependent)
    Available Since
    March 30, 2018
    Availability
    Academic Institutions and Nonprofits only
Showing: 581 - 600 of 29147 results